Moreover, autoantibodies against CRT (anti‐CRT Ab) have been reported in the serum of patients with various solid tumors such as hepatic, colorectal, pancreatic, breast and bladder cancers.9, 10, 11, 12. Here, CALR is linked to urinary bladder carcinoma.